Last updated by The POOG on September 17, 2020.

under construction

This page capture items of particular interest that don’t fit into any of the main articles on COVID-19. As such, they are not researched but are recorded with a link-back to the source from which a researcher may move forward.

Best Practices

To date, Sweden has shown to have had the most effective and least damaging approach economically[1].

Lockdowns

xxx

Death Rate

Testing

The public is widely uninformed or misinformed about the efficacy and availability of certain types of tests. Now we will track new developments.

An Israeli Israeli firm, Newsight Imaging, has developed a saliva test[2] that returns a result in less than a second and a 95% accuracy at a cost of less than $0.25 per test. It is in clinical trials.

Symptomatic Versus Asymptomatic

In the early stages of the disease, detection of infected individuals depended largely on their having symptoms serious enough to send them seeeking medical care at which point testing may be done. There were neither the resources nor the inclination to perform tests on the general population seeking asymptomatic infected individuals.

Over time, for proper epidemiological assessment, small studies were done on selected populations to assess the percentage of asymptomatic infections.

Over time, for proper epidemiological assessment, small studies were done on selected populations to assess the percentage of asymptomatic infections.

A Review of Some Studies

A Spanish study[1] of 35,883 households reported that:

Our findings confirm that at least a third of individuals who have developed antibodies against SARS-CoV-2 were asymptomatic.

[

References

  1. Sweden Hits COVID-19 “Triple Whammy”: No Lockdowns, Low Deaths & Minimal Economic Damage.
  2. Israeli Hospital Trials Fast Saliva Test for COVID-19.
  3. Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, a, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Lancet. July 06, 2020. DOI:https://doi.org/10.1016/S0140-6736(20)31483-5

Unprocessed References